The Diagnosis and Treatment of Sjögren's Syndrome.
暂无分享,去创建一个
[1] L. Criswell,et al. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts , 2017, Arthritis & rheumatology.
[2] K. Sivils,et al. Genetics in Sjögren Syndrome. , 2016, Rheumatic diseases clinics of North America.
[3] T. Dörner,et al. The Prevalence of Dental Implants and Related Factors in Patients with Sjögren Syndrome: Results from a Cohort Study , 2016, The Journal of Rheumatology.
[4] J. Garrigue,et al. Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease: A Multicenter Randomized Trial , 2016, European journal of ophthalmology.
[5] T. Witte,et al. Sjögren-Syndrom , 2016, DMW Deutsche Medizinische Wochenschrift.
[6] D. Cornec,et al. [Clinical usefulness of salivary gland ultrasonography in Sjögren's syndrome: Where are we now?]. , 2016, La Revue de medecine interne.
[7] X. Mariette,et al. Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations , 2016, Expert review of clinical immunology.
[8] B. Cochener,et al. The Differential Diagnosis of Dry Eyes, Dry Mouth, and Parotidomegaly: A Comprehensive Review , 2015, Clinical Reviews in Allergy & Immunology.
[9] E. Matteson,et al. Rate, risk factors and causes of mortality in patients with Sjögren's syndrome: a systematic review and meta-analysis of cohort studies. , 2015, Rheumatology.
[10] R. Jonsson,et al. Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling , 2015, Arthritis & rheumatology.
[11] Ami A. Shah,et al. Molecular Subsetting of Interferon Pathways in Sjögren's Syndrome , 2015, Arthritis & rheumatology.
[12] J. Buyon,et al. The clinical spectrum of autoimmune congenital heart block , 2015, Nature Reviews Rheumatology.
[13] Philippe Ravaud,et al. EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide , 2015, RMD Open.
[14] A. Shahane,et al. The epidemiology of Sjögren’s syndrome , 2014, Clinical epidemiology.
[15] R. Zhong,et al. Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis , 2014, Annals of the rheumatic diseases.
[16] J. Pepose,et al. Rethinking dry eye disease: a perspective on clinical implications. , 2014, The ocular surface.
[17] B. Kostov,et al. Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). , 2014, Rheumatology.
[18] P. Ravaud,et al. Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI) , 2014, Annals of the rheumatic diseases.
[19] P. Ravaud,et al. Serum Levels of Beta2-Microglobulin and Free Light Chains of Immunoglobulins Are Associated with Systemic Disease Activity in Primary Sjögren’s Syndrome. Data at Enrollment in the Prospective ASSESS Cohort , 2013, PloS one.
[20] F. Hiepe,et al. Neurologische Manifestationen bei Kollagenosen , 2012, Zeitschrift für Rheumatologie.
[21] M. Dalakas,et al. Peripheral neuropathies in Sjögren's syndrome: a critical update on clinical features and pathogenetic mechanisms. , 2012, Journal of autoimmunity.
[22] B. Segal,et al. Primary Sjogren’s syndrome: cognitive symptoms, mood, and cognitive performance , 2012, Acta neurologica Scandinavica.
[23] J. Pers,et al. Treatment of primary Sjögren syndrome , 2012, Nature Reviews Rheumatology.
[24] J. Anaya,et al. HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies. , 2012, Autoimmunity reviews.
[25] T. Dörner,et al. Fatigue and depression predict physician visits and work disability in women with primary Sjögren's syndrome: results from a cohort study. , 2012, Rheumatology.
[26] H. Worthington,et al. Interventions for the management of dry mouth: topical therapies. , 2011, The Cochrane database of systematic reviews.
[27] A. Villa,et al. Risk factors and symptoms associated with xerostomia: a cross-sectional study. , 2011, Australian dental journal.
[28] L. Criswell,et al. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants. , 2011, Arthritis and rheumatism.
[29] R. Jonsson,et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome , 2011, Annals of the rheumatic diseases.
[30] D. Pisetsky. Antinuclear antibodies in healthy people: the tip of autoimmunity's iceberg? , 2011, Arthritis research & therapy.
[31] M. Crow,et al. Activation of the type I interferon pathway in primary Sjogren's syndrome. , 2010, Journal of autoimmunity.
[32] Mimi Y. Kim,et al. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine , 2010, Annals of the rheumatic diseases.
[33] B. Segal,et al. Oral involvement in primary Sjögren syndrome. , 2008, Journal of the American Dental Association.
[34] P. Emery,et al. Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study , 2008, Annals of the rheumatic diseases.
[35] H. Moutsopoulos. Sjögren’s Syndrome or Autoimmune Epithelitis? , 2007, Clinical immunology and immunopathology.
[36] P Rosenthal,et al. Gas-permeable scleral contact lens therapy in ocular surface disease. , 2000, American journal of ophthalmology.
[37] H. Haga,et al. Renal involvement in primary Sjögren's syndrome. , 2000, QJM : monthly journal of the Association of Physicians.
[38] R. Matthay,et al. Pulmonary manifestations of Sjögren's syndrome. , 1998, Clinics in chest medicine.
[39] H. Worthington,et al. Interventions for the management of dry mouth: non-pharmacological interventions. , 2013, The Cochrane database of systematic reviews.